SEARCH

SEARCH BY CITATION

References

  • 1
    Esteban JI, Lopez-Talavera JC, Genesca J, Madoz P, Viladmiu L, Muniz E, Martin-Vega C, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115: 443449.
  • 2
    Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontisso P, Ruol A. Hepatitis C viremia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992; 340: 697698.
  • 3
    Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, Kamada T. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 1994; 19: 871875.
  • 4
    Morales TG, Sampliner RE, Bhattacharyya A, Alter MJ. Liver histology in anti-HCV-positive persons with normal or minimally elevated amino-transferases. J Clin Gastroenterol 1995; 21: 301305.
  • 5
    Shakil O, Conry-Cantilena C, Alter HJ, Hayashi P, Keiner DE, Tedeschi V, Krawczynski K, et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann Intern Med 1995; 123: 330337.
  • 6
    Serfaty L, Chazouilleres O, Pawlotsky JM, Andreani T, Pellet C, Poupon R. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996; 110: 291295.
  • 7
    Perrault J, McGill DB, Ott BJ, Taylor WF. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 1978; 74: 103106.
  • 8
    Knauer CM. Percutaneous biopsy of the liver as a procedure for outpatients. Gastroenterology 1978; 74: 101102.
  • 9
    Westaby D, MacDougall BR, Williams R. Liver biopsy as a day-case procedure: selection and complications in 200 consecutive patients. Br Med J 1980; 281: 13311332.
  • 10
    Janes CH, Lindor KD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 1993; 118: 9698.
  • 11
    Garcia-Tsao G, Boyer J. Outpatient liver biopsy: how safe is it? Ann Intern Med 1993; 118: 150153.
  • 12
    Everhart JE, Stolar M, Hoofnagle JH. Management of hepatitis C: a national survey of gastroenterologists and hepatologists. Hepatology 1997; 26 (suppl 1): 78S82S.
  • 13
    Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis 1995; 15: 7081.
  • 14
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431435.
  • 15
    Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading, and staging. Hepatology 1994; 19: 15131520.
  • 16
    The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994: 20: 1520.
  • 17
    Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240243.
  • 18
    Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 1993; 34 (suppl): S13S16.
  • 19
    Davis GL. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol 1994; 20: 13.
  • 20
    Cammell G, Younossi Z, Carey W. The utility of liver biopsy (L Bx) in diagnosis of hepatitis C (HCV) [Abstract]. Gastroenterology 1997; 112: A1236.
  • 21
    Bennett WG, Wong JB, Koff RS, Ishida H, Beck JR, Pauker SG. What is the optimal pretreatment evaluation of chronic hepatitis C [Abstract] ? Hepatology 1996; 24: 384A.
  • 22
    Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, et al. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial. N Engl J Med 1989; 321: 15011506.
  • 23
    Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, et al. A comparison of three interferon alfa-2b regimens for the long term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med 1995; 332: 14571462.
  • 24
    Balart LA, Perrillo R, Roddenberry J, Regenstein F, Shim KY, Shieh YSC, Taylor B, et al. Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alfa treatment. Gastroenterology 1993; 104: 14721477.
  • 25
    Shindo M, Di Bisceglie AM, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon. Hepatology 1992; 15: 10131016.
  • 26
    Haber MM, West AB, Haber AD, Reuben A. Relationship of aminotransferases to liver histological status in chronic hepatitis C. Am J Gastroenterol 1995; 90: 12501257.
  • 27
    McCormick SE, Goodman ZD, Maydonovitch CL, Sjogren MH. Evaluation of liver histology, ALT elevation, and HCV RNA liter in patients with chronic hepatitis C. Am J Gastroenterol 1996; 91: 15161522.
  • 28
    Healey CJ, Chapman RWG, Fleming KA. Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. Gut 1995; 37: 274278.
  • 29
    Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 15011504.
  • 30
    Gordon SC, Kodali VP, Silverman AL, Dmuchowski CF, Urdea MS, Chan CS, Wilber JC. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol 1994; 89: 14581461.
  • 31
    Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, Diquattro O, et al. Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology 1994; 19: 273279.
  • 32
    Nousbaum JP, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C, the Colloborative Study Group. Hepatitis C virus type Ib (II) infection in France and Italy. Ann Intern Med 1995; 122: 161168.
  • 33
    Kato N, Yokosuka O, Hosoda K, Ito Y, Ohio M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993; 18: 1620.
  • 34
    Gretch D, Corey L, Wilson J, dela Rosa C, Willson R, Carithers R, Busch M, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-liter viremia correlates with advanced stage of disease. J Infect Dis 1994; 169: 12191225.
  • 35
    Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Boden-heimer HC, Balart LA el al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology 1993; 104: 595603.
  • 36
    Cohen C, Berson SD. Liver cell dysplasia in normal, cirrhotic, and hepatocellular carcinoma patients. Cancer 1986; 57: 15351538.
  • 37
    Thomas RM, Berman JJ, Yeller RA, Moore GW, Hutchins GM. A DNA aneuploid lesion with distinct morphologic features. Hum Pathol 1992; 23: 496503.